Inspirational Stories

After initial chemo and radiation for stage 4 diffuse large B-cell lymphoma (DLBCL), I went into remission for 10 months. I had more chemo but couldn't tolerate it. CAR T-cell therapy seemed to be my best option. I received Yescarta® in March 2022. I was in the hospital for three weeks. I had some side effects, but they were treated immediately and resolved. I have been in remission for 19 months. I have had some residual effects ― low white blood cells which are slowly increasing, low hemoglobin which has finally come up to normal, and low immunoglobulin. I am getting my first dose of IVIG today. These effects are minor, and I am really happy to have more time with my family thanks to Yescarta®.